Study S000453

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06706284
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: RECRUITING
Enrollment: 50
Start: 2025-04-11
Primary completion: 2028-09-01
Lead sponsor: Marzieh Salehi
Conditions: Spinal Cord Injuries; Type 2 Diabetes
Interventions: DRUG:Semaglutide Injectable Product; OTHER:Placebo
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: NIH:R01DK140144-02

Registered primary outcomes

Glucose tolerance [Baseline to 24 weeks]
Insulin action [Baseline to 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.